The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. Afrezza (insulin human) is the same as regular insulin but in a new inhaled form.
How is Tresiba usually taken?
Dosing for Tresiba will be different for every person, but it’s typically injected subcutaneously once daily at any time of the day.
For more information take a look at the manufacturer website here.
How is Ryzodeg usually taken?
Dosing for Ryzodeg will also be different for each person, but it will usually be injected subcutaneously once or twice daily with any main meal. Ryzodeg doesn’t have an official website yet, but look for more information to come.
What dosage form(s) and strength(s) will Tresiba and Ryzodeg be available in?
Tresiba will be available as a FlexTouch disposable prefilled pen in two strengths: U-100 (100 units/mL) in 5-pen packages, and U-200 (200 units/mL) in 5-pen packages.
Ryzodeg will also be available as a FlexTouch pen, but only in the U-100 (100 units/mL) strength, and only in 5-pen packages.
Are there any benefits of using Tresiba compared to other long-acting insulin products?
Tresiba has a more flexible dosing schedule. According to the manufacturer Tresiba can last up to 42 hours which allows you to use it at any time of day.